Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 41 min ago
PreprintCC BY-NC-NDmedRxiv

Electronic Health Record-Based Machine-Learning for Cardiac Arrhythmia Identification in Adults with High-Risk Chronic Disease: Model Development and Validation Study

  1. 1Lucem Health, Inc

Abstract

Background: Cardiac arrhythmias may remain unrecognized in adults with chronic disease. Established risk scores primarily address atrial fibrillation. Objective: To develop and internally evaluate an electronic health record (EHR)-based machine-learning model to identify patients more likely to receive a documented cardiac arrhythmia diagnosis. Methods: We retrospectively evaluated EHR data (2018-2025) from one healthcare organization among adults with type 2 diabetes, chronic obstructive pulmonary disease, chronic kidney disease, or coronary artery disease. Logistic regression, random forest, and XGBoost were compared. XGBoost was selected using internal validation, reduced to 30 features using Shapley additive explanations, and evaluated in a holdout set with data ending one day before the index date. Sensitivity analyses excluded information recorded within 30, 90, or 180 days before the index date. An atrial fibrillation/flutter-specific analysis compared XGBoost with CHARGE-AF and HARMS2-AF. Results: Among 30,356 patients, 6,835 (22.5%) had a qualifying arrhythmia diagnosis. In 3,051 holdout patients, XGBoost achieved an area under the receiver operating characteristic curve (AUROC) of 0.894 (95% CI 0.879-0.908) and an area under the precision-recall curve of 0.792 (95% CI 0.763-0.822). At a 0.5 threshold, sensitivity was 0.564, specificity 0.971, and precision 0.857. AUROC remained 0.896-0.897 across earlier cutoffs. In the common score-calculable atrial fibrillation/flutter subset (n = 2,436), AUROCs were 0.883 for XGBoost, 0.712 for CHARGE-AF, and 0.554 for HARMS2-AF. Conclusions: XGBoost demonstrated strong internal discrimination for documented arrhythmias. External validation and prospective evaluation are needed to assess generalizability and clinical utility.

Related

  1. Development and Internal Validation of an Electronic Medical Record-Based Machine Learning Model for Frailty Prediction in Hospitalized Patients: Retrospective Cohort Study.
    Georgina Christine Laurea Szabo, Madison Bills, Matthew Williams +3
    JMIR medical informaticsPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMCDOAJ
  2. Machine Learning–Based Prediction of Major Postoperative Complications After Noncardiac Surgery Under General Anesthesia Using Routinely Available Electronic Health Record Data: Retrospective Multicenter Development and Validation Study
    Takuya Nishino, Hiroshi Mase, Chol Kim +3
    JMIR Perioperative MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicinePMC
  3. Screening for patients at risk for cardiac amyloidosis via electronic health records: A multicenter machine learning development and validation study
    Clemens P. Spielvogel, David Kersting, David Haberl +24
    PLOS Digital HealthPeer-reviewedCC BY 4.0Full textCardiovascular medicineEpidemiology & public healthPLOS
  4. From risk factors to individualized prediction: development and internal validation of a machine learning model for early identification of postoperative pneumonia after lung cancer surgery.
    Sabrina Petrovic, Tilen Gabršček, Bojana Beovic +7
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Prediction of incident inflammatory bowel disease from routine electronic health records: development and external validation of a longitudinal machine learning model
    G. Onal, A. Ayati, M.-Y. Chen +2
    medRxivPreprintCC BY-NC-NDFull textGeneral medicinemedRxiv
BibTeX
@misc{goel2026electronic,
  title = {{Electronic Health Record-Based Machine-Learning for Cardiac Arrhythmia Identification in Adults with High-Risk Chronic Disease: Model Development and Validation Study}},
  author = {M. Goel and S. Matlock and Y. Karasu Benyes and N. Narayanan and J. Howard and T. G. Brazeal and C. Cogan and E. Navarro and A. Petrus},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.30.26366947},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.30.26366947v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Electronic Health Record-Based Machine-Learning for Cardiac Arrhythmia Identification in Adults with High-Risk Chronic Disease: Model Development and Validation Study
AU  - M. Goel
AU  - S. Matlock
AU  - Y. Karasu Benyes
AU  - N. Narayanan
AU  - J. Howard
AU  - T. G. Brazeal
AU  - C. Cogan
AU  - E. Navarro
AU  - A. Petrus
PY  - 2026
DA  - 2026/10/30
PB  - medRxiv
DO  - 10.64898/2026.10.30.26366947
UR  - https://www.medrxiv.org/content/10.64898/2026.10.30.26366947v1
AB  - Background: Cardiac arrhythmias may remain unrecognized in adults with chronic disease. Established risk scores primarily address atrial fibrillation. Objective: To develop and internally evaluate an electronic health record (EHR)-based machine-learning model to identify patients more likely to receive a documented cardiac arrhythmia diagnosis. Methods: We retrospectively evaluated EHR data (2018-2025) from one healthcare organization among adults with type 2 diabetes, chronic obstructive pulmonary disease, chronic kidney disease, or coronary artery disease. Logistic regression, random forest, and XGBoost were compared. XGBoost was selected using internal validation, reduced to 30 features using Shapley additive explanations, and evaluated in a holdout set with data ending one day before the index date. Sensitivity analyses excluded information recorded within 30, 90, or 180 days before the index date. An atrial fibrillation/flutter-specific analysis compared XGBoost with CHARGE-AF and HARMS2-AF. Results: Among 30,356 patients, 6,835 (22.5%) had a qualifying arrhythmia diagnosis. In 3,051 holdout patients, XGBoost achieved an area under the receiver operating characteristic curve (AUROC) of 0.894 (95% CI 0.879-0.908) and an area under the precision-recall curve of 0.792 (95% CI 0.763-0.822). At a 0.5 threshold, sensitivity was 0.564, specificity 0.971, and precision 0.857. AUROC remained 0.896-0.897 across earlier cutoffs. In the common score-calculable atrial fibrillation/flutter subset (n = 2,436), AUROCs were 0.883 for XGBoost, 0.712 for CHARGE-AF, and 0.554 for HARMS2-AF. Conclusions: XGBoost demonstrated strong internal discrimination for documented arrhythmias. External validation and prospective evaluation are needed to assess generalizability and clinical utility.
ER  -